China Pharma Holdings CPHI Q3 2011 Earnings EPS Miss Weighs on Sentiment FISI Q1 2026 Earnings EPS Surges Past Estimates Stock Gains 24 ABUS Q1 2026 Earnings Wider Loss Than Expected as Biotech Reports No Revenue UGRO Q3 2025 Earnings Significant EPS Miss Amidst Industry Challenges ODYS Q1 2026 Earnings EPS Miss Widens as PreRevenue Company Navigates Development Stage Metalla Royalty Streaming Q1 2026 Earnings EPS Misses Estimates but Stock Rises 545 on Strategic Progress EDAP Q4 2025 Earnings EPS Miss Weighs on Shares Amid Operational Headwinds Keysight Technologies Q1 2026 Earnings EPS Surges Past Estimates Stock Gains SPOT Q1 2026 Earnings Strong EPS Beat Amid Mixed Market Sentiment Kairos Pharma Ltd KAPA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Stage Continues Rapid7 Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction NVEC Q1 2026 Earnings EPS of 102 Reported Shares Advance